Flow minimal residue disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhoood acute lymphoblastic leukemia

  1. Lookup NU author(s)
  2. Kate Wilson
  3. Marian Case
  4. Lynne Minto
  5. Professor Simon Bailey
  6. Dr Nicholas Bown
  7. Sally Lawson
  8. Professor Josef Vormoor
  9. Dr Julie Irving
Author(s)Wilson K, Case M, Minto L, Bailey S, Bown N, Jesson J, Lawson S, Vormoor J, Irving J
Publication type Article
JournalHaematologica
Year2009
Volume95
Issue4
Pages679-683
ISSN (print)0390-6078
ISSN (electronic)1592-8721
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Flow cytometric minimal residual disease (MRD) monitoring could become more powerful if directed towards the disease-maintaining leukaemic stem cell (LSC) compartment. Using a cohort of 48 children with B lineage acute lymphoblastic leukamia (ALL), we sought the newly proposed candidate-LSC population, CD34+CD38lowCD19+, at presentation and in end of induction bone marrow samples. We identified the candidate LSC population in 60% of diagnostic samples and its presence correlated with expression of CD38, relative to that of normal B cell progenitors. In addition, the candidate LSC was not detectable in all MRD positive samples. The absence of the population in 40% of diagnostic and 40% of MRD positive samples does not support the use of this phenotype as a generic biomarker to track LSCs and suggests that that this phenotype may be an artifact of CD38 under-expression rather than a biologically distinct LSC population.
PublisherFondazione Ferrata Storti
URLhttp://dx.doi.org/10.3324/haematol.2009.011726
DOI10.3324/haematol.2009.011726
Actions    Link to this publication
Share